Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions

KA Markey, SP Mollan, RH Jensen… - The Lancet …, 2016 - thelancet.com
Idiopathic intracranial hypertension is a disorder characterised by raised intracranial
pressure that predominantly affects young, obese women. Pathogenesis has not been fully …

Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management

SP Mollan, F Ali, G Hassan-Smith, H Botfield… - Journal of Neurology …, 2016 - jnnp.bmj.com
Idiopathic intracranial hypertension (IIH) is a rare but important disease associated with
significant morbidity. There is an expected rise in prevalence in line with the escalating …

Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment …

M Wall, MP McDermott, KD Kieburtz, JJ Corbett… - Jama, 2014 - jamanetwork.com
Importance Acetazolamide is commonly used to treat idiopathic intracranial hypertension
(IIH), but there is insufficient information to establish an evidence base for its use. Objective …

European headache federation guideline on idiopathic intracranial hypertension

J Hoffmann, SP Mollan, K Paemeleire, C Lampl… - The journal of headache …, 2018 - Springer
Abstract Background Idiopathic Intracranial Hypertension (IIH) is characterized by an
elevation of intracranial pressure (ICP no identifiable cause. The aetiology remains largely …

Papilledema: a review of etiology, pathophysiology, diagnosis, and management

JS Xie, L Donaldson, E Margolin - Survey of Ophthalmology, 2022 - Elsevier
Papilledema is optic nerve head edema secondary to raised intracranial pressure (ICP). It is
distinct from other causes of optic disk edema in that visual function is usually normal in the …

Idiopathic intracranial hypertension: a step change in understanding the disease mechanisms

A Yiangou, SP Mollan, AJ Sinclair - Nature Reviews Neurology, 2023 - nature.com
The understanding of idiopathic intracranial hypertension (IIH) has evolved over the past few
years. Previously, IIH was considered a disease exclusively affecting the neuro-ophthalmic …

Idiopathic intracranial hypertension: pathophysiology, diagnosis and management

MTM Wang, MT Bhatti, HV Danesh-Meyer - Journal of Clinical …, 2022 - Elsevier
Idiopathic intracranial hypertension (IIH) is characterized by increased intracranial pressure,
manifested by papilledema and radiological findings, in the absence of an identifiable …

Papilledema: epidemiology, etiology, and clinical management

M Rigi, SJ Almarzouqi, ML Morgan, AG Lee - Eye and brain, 2015 - Taylor & Francis
Papilledema is optic disc swelling due to high intracranial pressure. Possible conditions
causing high intracranial pressure and papilledema include intracerebral mass lesions …

Cerebrospinal fluid analysis

B Shahan, EY Choi, G Nieves - American Family Physician, 2021 - aafp.org
Cerebrospinal fluid (CSF) analysis is a diagnostic tool for many conditions affecting the
central nervous system. Urgent indications for lumbar puncture include suspected central …

[HTML][HTML] OCT: new perspectives in neuro-ophthalmology

G Rebolleda, L Diez-Alvarez, A Casado… - Saudi Journal of …, 2015 - Elsevier
Optical coherence tomography (OCT) has become essential to evaluate axonal/neuronal
integrity, to assess disease progression in the afferent visual pathway and to predict visual …